Impact Science Ventures is an early-stage (pre-seed, seed, Series A) venture capital firm investing in science-based technology innovation driving industrial decarbonization and sustainability in critical trillion-dollar global markets including energy, manufacturing, materials, and agriculture. With founding roots from Activate, the nation's premier accelerator for hard science start-ups backed by the Department of Energy, our team helped build the government-backed deep tech incubation system and has since invested in market leaders such as Antora, Brimstone, Fervo Energy, and Twelve.

Capita3 is an early-stage venture capital fund investing in women startup founders and the companies they're building.

University of Chicago Booth School of Business Social New Venture Challenge Spring 2022

Claros Technologies is a woman-founded VC-backed deep tech start-up harnessing green chemistry and advanced material science to develop scalable platform technologies enabling clean, sustainable, and fully closed-loop industrial processes. Spun out with IP from the University of Minnesota, our mission is to solve problems without creating new ones starting first with our global PFAS contamination crises. We are commercializing a UV-based PFAS destruction technology proven to fully defluorinate 99.99% of long, short, and ultra-short-chain PFAS in water.

With over $400 million raised, 3x5 Partners is a venture capital firm investing in passionate entrepreneurs developing innovative healthcare and climate solutions. Established in Portland, Oregon in 2011, 3x5 has delivered both top returns to investors and meaningful impact to the world through investments in early-stage biotechnology, medical diagnostics & devices, water, food & agriculture, energy, and waste & recycling companies.Selected Transaction Experience: - Enzinc $4.5M Seed (Lead) – Breakthrough mircosponge anode technology enabling mobility and long-duration stationary zinc batteries at scale- Claros Technologies $5M Series A (Lead) – Advanced materials nanotechnology platform with initial applications in environmental remediation (PFAS) and functional textiles- Koya Medical $28M Series B (Lead) – Novel medical devices and treatment platform for incurable lymphedema and venous diseases- Fervo Energy $138M Series C, $28M Series B, $10.5M Series A (Co-Lead) – Commercializing proprietary geothermal technology for a 100% clean energy grid- SOURCE Global, PBC $90M Series C/C1 – Renewable, infrastructureless clean drinking water solution serving communities, businesses, governments, and households globally through Hydropanel technology- Kaleidoscope $10M Series A (Co-Lead) – Cloud-based marketplace matching relationships, opportunities, and disbursements between providers and seekers of educational grants and scholarships- Arch Oncology $105M Series C (Co-Lead) – Clinical stage immuno-oncology company with differentiated anti-CD47 antibody for treatment of patients with solid tumors and hematologic malignancies

Services & industrial technology investment banking of public/private and corporate/financial sponsor clients including M&A, fixed income issuances, and equity capital markets transactions